Outcomes of a decision support prompt in community pharmacy-dispensing software to promote step-down of proton pump inhibitor therapy

British Journal of Clinical Pharmacology

Volumn 71, Issue 5, 2011, Pages 780-784

  Curtain, Colin ^a   Peterson, Gregory M ^a   Tenni, Peter ^a   Bindoff, Ivan K ^a   Williams, Mackenzie ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Clinical decision support systems; Clinical pharmacy information systems; Community pharmacy; Computer assisted drug therapy; Gastro oesophageal reflux drug therapy; Proton pump inhibitors

Indexed keywords

ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ARTICLE; AUSTRALIA; CLINICAL PRACTICE; COMMUNITY CARE; COMPUTER PROGRAM; CONTROLLED STUDY; COST CONTROL; DECISION SUPPORT SYSTEM; DRUG COST; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GASTROESOPHAGEAL REFLUX; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION SYSTEM; OUTCOMES RESEARCH; PHARMACIST; PHARMACY; PRIORITY JOURNAL; TREATMENT OUTCOME;

AUSTRALIA; COMMUNITY PHARMACY SERVICES; DECISION SUPPORT TECHNIQUES; DRUG COSTS; DRUG PRESCRIPTIONS; DRUG THERAPY, COMPUTER-ASSISTED; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PROTON PUMP INHIBITORS; SOFTWARE;

EID: 79953882384     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2010.03890.x     Document Type: Article

References (23)

1. Australian Health Information Council. AHIC electronic decision support systems report. In: Australian Health Information Council 2008.
2. Bates DW, Kuperman GJ, Wang S, Gandhi T, Kittler A, Volk L, Spurr C, Khorasani R, Tanasijevic M, Middleton B. Ten commandments for effective clinical decision support: making the practice of evidence-based medicine a reality. J Am Med Inform Assoc 2003; 10: 523-30.
3. Calabretto J, Warren J, Bird L. Pharmacy decision support: where is it? A systematic literature review. Int J Pharm Pract 2005; 13: 157-63.
4. Reeve JF, Tenni PC, Peterson GM. An electronic prompt in dispensing software to promote clinical interventions by community pharmacists: a randomized controlled trial. Br J Clin Pharmacol 2007; 65: 377-85.
5. Hughes JD, Tanpurekul W, Keen NC, Ee HC. Reducing the cost of proton pump inhibitors by adopting best practice. Qual Prim Care 2009; 17: 15-21.
6. Mabasa VH, Ma J. Effect of a therapeutic maximum allowable cost (MAC) program on the cost and utilization of proton pump inhibitors in an employer-sponsored drug plan in Canada. J Manag Care Pharm 2006; 12: 371-76.
7. Mat Saad AZ, Collins N, Lobo MM, O'Connor HJ. Proton pump inhibitors: a survey of prescribing in an Irish general hospital. Int J Clin Pract 2005; 59: 31-4.
8. McMullin ST, Lonergan TP, Rynearson CS. Twelve-month drug cost savings related to use of an electronic prescribing system with integrated decision support in primary care. J Manag Care Pharm 2005; 11: 322-32.
9. Batuwitage BT, Kingham JGC, Morgan NE, Bartlett RL. Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad Med J 2007; 83: 66-8.
10. Hebbard GS. Proton pump inhibitors: step-down to symptom control. In: Prescribing Practice Review for Primary Care: National Prescribing Service, 2009: 4.
11. Department of Veterans Affairs. PPIs in GORD: reduce the dose - keep the benefits. Therapeutic Brief 7. In: Department of Veterans Affairs. 2010.
12. Abbott R, Best J, Buckley N, Donovan J, Dowden J, Parker S, Rossi S. NPS News 46: proton pump inhibitors. In: NPS News: National Prescribing Service. 2006.
13. Peterson G, Tenni P, Jackson S, Bereznicki L, Hughes J, Kong D, Doran C, Williams M, Curtain C, Hughes J, Ellerton L, Bindoff I. Documenting clinical interventions in community pharmacy: PROMISe III. 2010.
14. Peterson GM, Tenni PT. Identifying, prioritising and documenting drug-related problems. Aust Pharm 2004; 23: 706-09.
15. Department of Health and Ageing. PhARIA pharmacy access/remoteness index of Australia. In: The University of Adelaide.
16. Gastroenterological Society of Australia. Gastro-oesophageal reflux disease in adults: guidelines for clinicians. In: Gastroenterological Society of Australia. 2008.
17. Department of Health and Ageing. Schedule of pharmaceutical benefits July 2009. In, Department of Health and Ageing, Canberra: Commonwealth of Australia. 2009.
18. Pharmacy Guild of Australia. 2008 Guild Digest. Canberra: Pharmacy Guild of Australia, 2008.
19. Humphries TL, Carroll N, Chester EA, Magid D, Rocho B. Evaluation of an electronic critical drug interaction program coupled with active pharmacist intervention. Ann Pharmacother 2007; 41: 1979-85.
20. Moxey A, Robertson J, Newby D, Hains I, Williamson M, Pearson SA. Computerized clinical decision support for prescribing: provision does not guarantee uptake. J Am Med Inform Assoc 2010; 17: 25-33.
21. Isaac TI, Weissman JS, Davis RB, Massagli M, Cyrulik A, Sands DZ, Weingart SN. Overrides of medication alerts in ambulatory care. Arch Intern Med 2009; 169: 305-11.
22. Peterson GM, Tenni PT, Kruup H, Hasan O, Reeve JF. Evaluation of Clinical Interventions within Community Pharmacy (Promise II). Canberra: Pharmacy Guild of Australia, 2003.
23. Stevenson FA, Greenfield SH, Jones M, Nayak A, Bradley CP. GPs' perceptions of patient influence on prescribing. Fam Pract 1999; 16: 255-61.